Unfortunately our Net Payout Yields model held onto the stock for that period, but at least the end result has been positive. As of the close today, each original Medco share would be worth $73.75. Now the key to holding Express Scripts going forward will be whether the combined company continues funding huge dividends and buybacks.
See our previous blog post after the original announcement.
Details from the PR:
- Following consummation of the acquisition, each share of pre-closing Medco common stock was converted into (i) the right to receive $28.80 in cash, without interest and (ii) 0.81 shares of common stock of the new Express Scripts
- The company expects synergies of $1 billion once fully integrated, which represents approximately 1 percent of the combined company's costs.
- The transaction is expected to be slightly accretive to earnings per share (excluding integration and deal-related costs and charges) in the first full year after closing and moderately accretive once fully integrated.
Long: ESRX via MHS shares. Please review the disclaimer page for more details.